background image

Paid Clinical Trials Knoxville

Discover 217 paid clinical trials in Knoxville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Remibrutinib vs. Teriflunomide

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Knoxville TN, Greenville SC, Suwanee GA, Nicholasville KYshow 59 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

LY3556050

Recruiting
PHASE2

Sponsor:

Eli Lilly and Company

Location:

Knoxville TN, Lexington KY, Hickory NC, Morehead City NCshow 29 more

Code:

NCT06074562

Conditions

Diabetic Peripheral Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3556050

Placebo

Chemotherapy with Endocrine Therapy

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Knoxville TN, Corbin KY, London KY, Greer SCshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Selumetinib vs. Carboplatin/Vincristine

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Knoxville TN, Greenville SC, Lexington KY, Atlanta GAshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Camizestrant

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Knoxville TN, Chattanooga TN, Greenville SC, Spartanburg SCshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Milvexian

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Oak Ridge TN, Chattanooga TN, Gainesville GA, Greenville SCshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Nivolumab, Ipilimumab, Cabozantinib

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Knoxville TN, Alcoa TN, Corbin KY, London KYshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

BLU-5937

Recruiting
PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Knoxville TN, Bristol TN, Lawrenceville GA, Rock Hill SCshow 67 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

Fianlimab & Cemiplimab

Recruiting
PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Knoxville TN, Nashville TN, Chapel Hill NC, Durham NCshow 25 more

Code:

NCT05608291

Conditions

Melanoma

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Fianlimab

Cemiplimab

Pembrolizumab

Placebo

Sacituzumab Govitecan

Recruiting
PHASE2

Sponsor:

Gilead Sciences

Location:

Knoxville TN, Atlanta GA, Nashville TN, Louisville KYshow 31 more

Code:

NCT03547973

Conditions

Metastatic Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Govitecan-hziy

Pembrolizumab

Cisplatin

Avelumab

Zimberelimab